Cargando…
Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
Since the first reports from December 2019, COVID-19 caused an overwhelming global pandemic that has affected 223 countries, seriously endangering public health and creating an urgent need for effective drugs to treat SARS-CoV-2 infection. Currently, there is a lack of safe, effective, and specific...
Autores principales: | Zhao, Lei, Li, Song, Zhong, Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916227/ https://www.ncbi.nlm.nih.gov/pubmed/35281901 http://dx.doi.org/10.3389/fphar.2022.840639 |
Ejemplares similares
-
Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
por: Zhong, Wu, et al.
Publicado: (2022) -
Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
por: Zhong, Wu, et al.
Publicado: (2022) -
Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
por: Chen, Wei, et al.
Publicado: (2021) -
Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021) -
Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021)